Condition: Stroke · Atrial Fibrillation · Sponsor: Population Health Research Institute
Multinational, investigator-initiated study of oral anticoagulation versus no anticoagulation for the prevention of stroke and other adverse cardiovascular events in patients with transient atrial fibrillation occurring transiently with stress and additional stroke risk factors.
This description comes directly from the study's public registry record.
Cassie McDonald · 1-905-594-0560 · aspireaf@phri.ca
Always discuss trial participation with your own doctor first.
| Cedars-Sinai Medical Center | Los Angeles, California, United States | Recruiting |
| Mcgovern Medical School at University of Texas | Houston, Texas, United States | Recruiting |
| Clinica Coronel Suarez | Coronel Suárez, Buenos Aires, Argentina | Recruiting |
| Instituto de Investigaciones Clinicas Rosario | Rosario, Santa Fe Province, Argentina | Recruiting |
| Instituto Cardiovascular de Rosario | Rosario, Santa Fe Province, Argentina | Recruiting |
| Centro Integral de Arritmias de Tucuman (CIAT) | San Miguel de Tucumán, Tucumán Province, Argentina | Recruiting |
| Hospital Municipal Chivilcoy | Chivilcoy, Argentina | Recruiting |
| Sanatorio Cisma | San Miguel de Tucumán, Argentina | Recruiting |
| Hospital Privado de Rosario | Santa Fe, Argentina | Not Yet Recruiting |
| Canberra Hospital | Garran, Australian Capital Territory, Australia | Recruiting |
| Bankstown Hospital | Bankstown, New South Wales, Australia | Recruiting |
| Royal Prince Alfred Hospital | Camperdown, New South Wales, Australia | Recruiting |
+ 93 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT03968393